tiprankstipranks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market
SNOA
Sonoma Pharmaceuticals
RESEARCH TOOLSreports
Want to see SNOA full AI Analyst Report?

Sonoma Pharmaceuticals (SNOA) Income Statement

352 Followers

Sonoma Pharmaceuticals Income Statement

Last quarter (Q3 2026), Sonoma Pharmaceuticals's total revenue was $4.35M, an increase of 22.03% from the same quarter last year. In Q3, Sonoma Pharmaceuticals's net income was $-819.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Jun 22Jun 21
Total Revenue
$ 14.29M$ 12.73M$ 13.27M$ 12.63M$ 18.63M
Gross Profit
$ 5.46M$ 4.75M$ 4.48M$ 3.99M$ 6.56M
Operating Expenses
$ 9.18M$ 9.45M$ 9.05M$ 9.88M$ 10.01M
Depreciation and Amortization
$ 138.00K$ 176.00K$ 125.00K$ 186.00K$ 227.00K
EBITDA
$ -3.57M$ -4.53M$ -4.45M$ -5.70M$ -3.22M
Operating Income
$ -3.71M$ -4.70M$ -4.57M$ -5.89M$ -3.45M
Other Income/Expenses
$ 803.00K$ -330.00K$ -614.00K$ 469.00K$ -453.00K
Pretax Income
$ -2.91M$ -5.03M$ -5.18M$ -5.42M$ -3.90M
Net Income
$ -3.46M$ -4.83M$ -5.15M$ -5.09M$ -3.95M
Per Share Metrics
Basic EPS
$ -2.79$ -5.32$ -15.18$ -19.17$ -23.65
Diluted EPS
$ -2.79$ -5.32$ -15.18$ -19.17$ -23.65
Weighted Average Shares Outstanding
 1.24M 909.00K 339.40K 265.30K 199.60K
Weighted Average Shares Outstanding (Diluted)
 1.24M 909.00K 339.40K 265.30K 199.60K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History